Evidence map›Paper›PMID 36438691›Full record

ArticleComputational intelligence and neuroscience2022

Space-Distributed Traffic-Enhanced LSTM-Based Machine Learning Model for COVID-19 Incidence Forecasting.

Mario Muñoz-Organero

Abstract read
In one paragraph

Article in Computational intelligence and neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Mario Muñoz-OrganeroTelematic Engineering Department, Universidad Carlos III de Madrid, Leganes 28911, Madrid, Spain.ORCID https://orcid.org/0000-0003-4199-2002

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 virus continues to generate waves of infections around the world. With major areas in developing countries still lagging behind in vaccination campaigns, the risk of new variants that can cause re-infections worldwide makes the monitoring and forecasting of the evolution of the virus a high priority. Having accurate models able to forecast the incidence of the spread of the virus provides help to policymakers and health professionals in managing the scarce resources in an optimal way. In this paper, a new machine learning model is proposed to forecast the spread of the virus one-week ahead in a geographic area which combines mobility and COVID-19 incidence data. The area is divided into zones or districts according to the location of the COVID-19 measuring points. A traffic-driven mobility estimate among adjacent districts is proposed to capture the spatial spread of the virus. Traffic-driven mobility in adjacent districts will be used together with COVID-19 incidence data to feed a new deep learning LSTM-based model which will extract patterns from mobility-modulated COVID-19 incidence spatiotemporal data in order to optimize one-week ahead estimations. The model is trained and validated with open data available for the city of Madrid (Spain) for 3 different validation scenarios. A baseline model based on previous literature able to extract temporal patterns in COVID-19 incidence time series is also trained with the same dataset. The results show that the proposed model, based on the combination of traffic and COVID-19 incidence data, is able to outperform the baseline model in all the validation scenarios.

Indexed as

COVID-19CitiesForecastingHumansIncidenceMachine Learning

Identifiers

PMID36438691
PMCPMC9699744

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.